Review article : Pain in prostatic cancer
- 1 July 1990
- journal article
- review article
- Published by SAGE Publications in Palliative Medicine
- Vol. 4 (3) , 173-184
- https://doi.org/10.1177/026921639000400303
Abstract
The authors report an overview of current specific antitumoral and other methods for treating the pain associated with advanced prostatic cancer. Pathological studies show that bone involvement is the main cause of pain. Bone and spinal metastases and pathological fracture are the most frequent challenges of this pathology. The role and results of chemotherapy, radiotherapy and hormonal treatments for pain relief are reported and discussed. Analgesic drugs are the mainstay of specific pain management, in which NSAIDs associated with opiates play an important role. Other forms of treatment (neural-blockade techniques) must be used only in selected cases. The authors conclude that the terminal stage of prostatic cancer requires multidisciplinary supportive care in which symptom control should be linked with active psychosocial help.Keywords
This publication has 122 references indexed in Scilit:
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unitJournal of Pain and Symptom Management, 1988
- Intraspinal morphine for cancer painActa Anaesthesiologica Scandinavica, 1987
- Pain in far-advanced cancerPain, 1982
- Hormone ReceptorsNew England Journal of Medicine, 1979
- Prostatic CarcinomaNew England Journal of Medicine, 1979
- Interpreting Cancer Survival RatesScience, 1977
- BREAST-CANCER OSTEOLYSIS, BONE METASTASES, AND ANTI-OSTEOLYTIC EFFECT OF ASPIRINThe Lancet, 1976
- TUMORS OF THE SPINE. A Follow‐up Study of 350 Patients with Neurosurgical ConsiderationsActa Psychiatrica Scandinavica, 1959
- THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASESAnnals of Surgery, 1940